Palantir's NHS cancer app is used by only six trusts, official figures show
Cancer 360, part of the £330 million Federated Data Platform, has been piloted for four years, but Freedom of Information replies show two trusts cited as successes logged zero users over 12 months, The Register reports.
Why it matters
NHS England has promoted Cancer 360 as proof that Palantir's platform speeds diagnosis, citing a Chelsea and Westminster pilot where diagnoses within 28 days rose from 72 to 85 percent. The new figures suggest uptake is far narrower than that messaging implies. Official data said six trusts used the app as of June and five were benefiting, without naming them, and those statistics have since been removed from the NHS England website. Watch for answers from the trusts and NHS England on the discrepancy, and for pressure on the wider Federated Data Platform contract.
Key facts
- Federated Data Platform contract worth £330 million
- Cancer 360 pilots began four years ago
- Six trusts using it as of June, five benefiting (official data)
- Two pilot trusts logged zero unique users in 12 months (FoI)
- East Lancashire reported one user and was not live
- Chelsea and Westminster pilot: 28-day diagnoses rose from 72% to 85%